Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonifer
- Development stage
- Unknown
- Lead developer
- FRiLAB
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tonifer is an oral antianemic syrup developed by FRiLAB. It is a fixed-dose combination containing ferric ammonium citrate (an iron source), folic acid (vitamin B9), and cyanocobalamin (vitamin B12). Tonifer is approved for the treatment and prevention of iron deficiency anemia, dimorphic anemia, and occasional tiredness or fatigue. It works by providing essential hematopoietic factors required for the synthesis of hemoglobin and the production of red blood cells.
- Brand names
- Tonifer
- Other names
- ferric ammonium citrate + folic acid + cyanocobalaminferric ammonium citrate + folic acid + vitamin B12
02
Targets
DHFR (Dihydrofolate reductase)MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)
Beyond the preview
Go deeper on Tonifer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonifer.